ID

22550

Descripción

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00350051

Link

https://clinicaltrials.gov/show/NCT00350051

Palabras clave

  1. 7/6/17 7/6/17 -
Subido en

7 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00350051

Eligibility Prostate Cancer NCT00350051

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have evidence of confirmed metastatic prostate cancer
Descripción

Metastatic Prostate Carcinoma Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C0332120
serum testosterone must be less than 50 ng/ml
Descripción

Serum testosterone measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428413
disease must be progressing despite anti-androgen therapy
Descripción

Antiandrogen therapy | Disease Progression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2]
C0242656
psa level must be elevated
Descripción

Raised prostate specific antigen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178415
additional criteria determined at screening visit
Descripción

Inclusion Criteria Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1524062
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any previous cytotoxic chemotherapy for prostate cancer
Descripción

Cytotoxic Chemotherapy Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0600139
use of any investigational drug in the last 4 weeks
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
symptomatic brain tumors requiring radiation to the brain
Descripción

Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006118
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0948319
UMLS CUI [2,2]
C0686904
active infection
Descripción

Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
additional criteria determined at screening visit
Descripción

Exclusion Criteria Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062

Similar models

Eligibility Prostate Cancer NCT00350051

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Metastatic Prostate Carcinoma Evidence of
Item
must have evidence of confirmed metastatic prostate cancer
boolean
C0936223 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Serum testosterone measurement
Item
serum testosterone must be less than 50 ng/ml
boolean
C0428413 (UMLS CUI [1])
Antiandrogen therapy | Disease Progression
Item
disease must be progressing despite anti-androgen therapy
boolean
C0279492 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
Raised prostate specific antigen
Item
psa level must be elevated
boolean
C0178415 (UMLS CUI [1])
Inclusion Criteria Additional
Item
additional criteria determined at screening visit
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic Chemotherapy Prostate carcinoma
Item
any previous cytotoxic chemotherapy for prostate cancer
boolean
C0677881 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Investigational New Drugs
Item
use of any investigational drug in the last 4 weeks
boolean
C0013230 (UMLS CUI [1])
Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for
Item
symptomatic brain tumors requiring radiation to the brain
boolean
C0006118 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0948319 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Exclusion Criteria Additional
Item
additional criteria determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial